CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Grant or award CHIEF COMMERCIAL OFFICER acquired 1,118 shares (grant or award)
- 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 469 shares (grant or award)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 577 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 2,004 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 507 shares (to pay taxes)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF ACCOUNTING OFFICER sold 9,051 shares at $22.45 ($203,195)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 36,372 shares at $22.25 ($809,277)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,409 shares at $21.06 ($261,334)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Agreement ended · Results of operations · Exit or restructuring costs
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF OPERATING OFFICER sold 14,000 shares at $19.57 ($273,980)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 14,000 shares at an average $18.24 ($255,413)
- 144 Insider Sale of Securities
Page 13 of 39 · 778 filings